Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.64 USD | +7.89% | +12.00% | -46.15% |
Financials (USD)
Sales 2022 | - | Sales 2023 | - | Capitalization | 17.64M |
---|---|---|---|---|---|
Net income 2022 | -17M | Net income 2023 | -10M | EV / Sales 2022 | - |
Net cash position 2022 | 13.25M | Net cash position 2023 | 3.84M | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.65
x | P/E ratio 2023 |
-1.53
x | Employees | 11 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 28.78% |
Latest transcript on Akari Therapeutics, Plc
1 week | +2.01% | ||
Current month | -1.30% | ||
1 month | +30.34% | ||
3 months | -36.40% | ||
6 months | -53.52% | ||
Current year | -51.28% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 15-08-31 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 23-07-18 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 15-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 16-05-31 |
Founder | 79 | 15-08-31 | |
Director/Board Member | 61 | 23-07-04 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1.64 | +7.89% | 3 980 |
24-05-20 | 1.52 | 0.00% | 22,630 |
24-05-17 | 1.52 | +2.70% | 20,155 |
24-05-16 | 1.48 | +1.37% | 6,966 |
24-05-15 | 1.46 | -2.67% | 9,076 |
Delayed Quote Nasdaq, May 20, 2024 at 04:30 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-51.28% | 12.04M | |
+9.58% | 115B | |
+12.41% | 107B | |
-12.38% | 22.31B | |
-3.32% | 21.6B | |
-3.35% | 18.23B | |
-38.57% | 17.62B | |
+7.51% | 14.26B | |
+35.67% | 12.37B | |
-24.50% | 8.28B |
- Stock Market
- Equities
- AKTX Stock